Bci-2-like protein bim and methods of use thereof
CA 2304124 A1 · Owner: Huang, David C. S. · Inventors: O'Reilly, Lorraine; O'Connor, Liam; Cory, Suzanne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to novel molecules capable of inter , alia, modulating apoptosis in mammalian cells and to genetic sequences encoding same. More particularly, the present invention relates to a novel member of the Bcl-2 family of proteins referred to herein as "Bim", and to , genetic sequences encoding same. The molecules of the present invention are useful, for example, in therapy, diagnosis antibody generation and as a , screening tool for therapeutic agents capable of modulating physiological cell death or survival and/or modulating cell cycle entry.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 17, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 17, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.